Navigation Links
Old as you want to be: Study finds most seniors feel younger
Date:12/2/2008

ANN ARBOR, Mich.---Older people tend to feel about 13 years younger than their chronological age.

That is one of the findings of a study forthcoming in the Journals of Gerontology: Psychological Science. The researchers analyzed the responses of 516 men and women age 70 and older who participated in the Berlin Aging Study, tracking how their perceptions about age and their satisfaction with aging changed over a six-year period.

"People generally felt quite a bit younger than they actually were, and they also showed relatively high levels of satisfaction with aging over the time period studied," said Jacqui Smith, a psychologist at the University of Michigan Institute for Social Research (ISR). Smith conducted the study with colleagues Anna Kleinspehn-Ammerlahn and Dana Kotter-Gruehn at the Max Planck Institute for Human Development in Berlin.

"We examined individual changes over time, and expected the gap to increase. But we were surprised to find that it was maintained, on average. Perhaps feeling about 13 years younger is an optimal illusion in old age," Smith said.

Smith and colleagues found that some of the oldest participants did feel even younger over time. But poor health reduced the gap between felt age and actual age.

The researchers also assessed how old people thought they looked, asking them: "How old do you feel when you look at yourself in a mirror?" They responded by selecting an age on a scale that ranged from 0 to 120 years. In general, at the start of the study people said they looked about 10 years younger than they were. By the end of the study, this gap had narrowed; people felt they looked only about seven years younger than their chronological age.

In general, women perceived their appearance as being closer to their actual age, Smith said. "Women saw themselves as about four years older than their male peers," she said. "There are several likely reasons for this gender gap in
'/>"/>

Contact: Diane Swanbrow
swanbrow@umich.edu
734-647-9069
University of Michigan
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones
2. Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes
3. Large study illustrates cardiac CT can effectively assess coronary artery disease
4. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
5. Nationwide study confirms PET as the most powerful imaging tool in cancer management
6. Study: Patient Harm More Common with Patient-Controlled Pain Medication
7. Study unmasks how ovarian tumors evade immune system
8. Study shows how shift workers can improve job performance and implement a realistic sleep schedule
9. Study Recruiting From Alzheimers-Prone Families
10. Aged care workers to leave industry en masse due to stress, warns University of Melbourne study
11. Study compares strategies for BK virus nephropathy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 1Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 1St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 2